We are live on ! Find out more
ADVM

Adverum Biotechnologies
ADVM

Delisted

ADVM was delisted on the 8th of December, 2025.

Back to rankings

65 hedge funds and large institutions have $67.3M invested in Adverum Biotechnologies in 2017 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 23 increasing their positions, 10 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,027% more call options, than puts

Call options by funds: $1.48M | Put options by funds: $131K

130% more repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 10

58% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 12

36% more capital invested

Capital invested by funds: $49.5M → $67.3M (+$17.8M)

12% more funds holding

Funds holding: 58 → 65 (+7)

1.13% more ownership

Funds ownership: 3.14% → 4.27% (+1.1%)

Holders
65
Holders Change
+7
Holders Change %
+12.07%
% of All Funds
1.47%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
19
Increased
23
Reduced
10
Closed
12
Calls
$1.48M
Puts
$131K
Net Calls
+$1.35M
Net Calls Change
+$1.36M

Top Buyers

Rank Fund Capital Flow
1
HCM
Highbridge Capital Management
New York
+$7.46M
2
RCMNY
Rubric Capital Management (New York)
New York
+$2.63M
3
Renaissance Technologies
Renaissance Technologies
New York
+$2.35M
4
Morgan Stanley
Morgan Stanley
New York
+$1.9M
5
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$1.65M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$3.36M
2
EC
EcoR1 Capital
California
-$2.79M
3
VMI
VHCP Management II
New York
-$1.02M
4
OAM
Oxford Asset Management
United Kingdom
-$521K
5
Schroder Investment Management Group
Schroder Investment Management Group
United Kingdom
-$350K
Name Holding Trade Value Shares
Change 		Change in
Stake
State Street
51
State Street
Massachusetts
$50K +$45.8K +1,391 New
Group One Trading
52
Group One Trading
Illinois
$48K +$26K +790 +134%
DTL
53
Dynamic Technology Lab
Singapore
$36K +$34K +1,033 New
IA
54
IFP Advisors
Florida
$21K – – –
Royal Bank of Canada
55
Royal Bank of Canada
Ontario, Canada
$20K -$66 -2 -0.4%
CHP
56
Cable Hill Partners
Oregon
$13K +$9.87K +300 New
Manulife (Manufacturers Life Insurance)
57
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$9K +$6.88K +209 +510%
Federated Hermes
58
Federated Hermes
Pennsylvania
$8K +$3.69K +112 +87%
Macquarie Group
59
Macquarie Group
Australia
$8K +$7.9K +240 New
AG
60
Advisor Group
Arizona
$7K – – –
HFM
61
Hartford Financial Management
Connecticut
$7K +$6.58K +200 New
MAM
62
Meeder Asset Management
Ohio
$5K – – –
EWM
63
Edge Wealth Management
New York
$1K – – –
JCM
64
Jacobi Capital Management
Pennsylvania
$1K – – –
BNP Paribas Financial Markets
65
BNP Paribas Financial Markets
France
$21 – – –
EC
66
EcoR1 Capital
California
– -$2.79M -76,295 Closed
VMI
67
VHCP Management II
New York
– -$1.02M -28,000 Closed
Schroder Investment Management Group
68
Schroder Investment Management Group
United Kingdom
– -$350K -10,146 Closed
ECM
69
Element Capital Management
New York
– -$129K -3,535 Closed
Squarepoint
70
Squarepoint
New York
– -$116K -3,180 Closed
Jane Street
71
Jane Street
New York
– -$108K -2,967 Closed
MAM
72
Marquette Asset Management
Minnesota
– -$95K -2,600 Closed
WCM
73
Wildcat Capital Management
New York
– -$55K -1,500 Closed
VF
74
Virtu Financial
New York
– -$53K -1,458 Closed
SCM
75
Stevens Capital Management
Pennsylvania
– -$42K -1,159 Closed
1 2
3
4

ADVM Hedge Fund Activity: Q4 2017 in Review

65 of the 4,410 institutional investors tracked by Wall St. Rank reported a position in Adverum Biotechnologies (ADVM) for Q4 2017, worth a combined $67.3M — up 36% from $49.5M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new ADVM positions and 12 closed out — a net gain of 7 holders — while 23 added to existing stakes and 10 trimmed.

The largest buyer was Highbridge Capital Management, adding an estimated $7.46M. The largest seller was Fidelity Investments, cutting an estimated $3.36M.

  • 65 institutional investors held Adverum Biotechnologies (ADVM) as of Q4 2017, up from 58 in Q3 2017.
  • Funds reported $67.3M of Adverum Biotechnologies stock for Q4 2017, up 36% quarter-over-quarter.
  • 19 funds opened new Adverum Biotechnologies positions in Q4 2017 and 12 closed out, a net change of +7 holders.
  • The largest Adverum Biotechnologies buyer in Q4 2017 was Highbridge Capital Management, an estimated $7.46M added.
  • The largest Adverum Biotechnologies seller in Q4 2017 was Fidelity Investments, an estimated $3.36M sold.

Based on aggregated 13F filings for Q4 2017.